Release Date: 30/04/14 08:28 Summary: Appendix 4C - quarterly and Operatinal Report Price Sensitive: Yes Download Document 523.9KB Download
MSB Mesoblast resubmits US FDA application for approval of Ryoncil in children with graft vs host disease; shares dip -4%